Literature DB >> 16286909

Pathophysiology of seroma in breast cancer.

Katsumasa Kuroi1, Kojiro Shimozuma, Tetsuya Taguchi, Hirohisa Imai, Hiroyasu Yamashiro, Shozo Ohsumi, Shinya Saito.   

Abstract

PURPOSE: Seroma is the most common complication of mastectomy. The aim of this systematic review is to clarify the pathophysiology of seroma.
MATERIALS AND METHODS: A computer-assisted MEDLINE search was conducted, and additional references were found in the bibliographies of these articles. The reference terms ''breast cancer'', ''mastectomy'', ''seroma'', ''lymphocele'' and ''lymphocyst'' were used as both keyword and subject terms. The search was limited to studies published in English.
RESULTS: The definition of seroma was highly variable across studies, but was most commonly a seroma large enough to be noticed by the patient or medical staff and affecting the patient's satisfaction in the immediate or acute postoperative period. So far, only limited data are available on the severity of seroma. With respect to the pathophysiology of seroma, the data indicated that several anatomical factors, especially dead space, likely contribute to seroma formation. However, it was obscure whether seroma was due to lymph-like fluid or exudate.
CONCLUSION: There is considerable variability in the way seroma is defined across studies, and its pathophysiology remains uncertain.

Entities:  

Mesh:

Year:  2005        PMID: 16286909     DOI: 10.2325/jbcs.12.288

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  37 in total

1.  Design of an injectable synthetic and biodegradable surgical biomaterial.

Authors:  Peter N Zawaneh; Sunil P Singh; Robert F Padera; Peter W Henderson; Jason A Spector; David Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Factors that Affect Drain Indwelling Time after Breast Cancer Surgery.

Authors:  Ömer Uslukaya; Ahmet Türkoğlu; Metehan Gümüş; Zübeyir Bozdağ; Ahmet Yılmaz; Hatice Gümüş; Şeyhmus Kaya; Mesut Gül
Journal:  J Breast Health       Date:  2016-07-01

3.  Feasibility of eradication of breast cancer cells remaining in postlumpectomy cavity and draining lymph nodes following intracavitary injection of radioactive immunoliposomes.

Authors:  Shihong Li; Beth Goins; Brian A Hrycushko; William T Phillips; Ande Bao
Journal:  Mol Pharm       Date:  2012-08-23       Impact factor: 4.939

4.  The volume and duration of wound drainage are independent prognostic factors for breast cancer.

Authors:  Yan Zhang; Hua Gao; Wei Gao
Journal:  Tumour Biol       Date:  2013-12-06

5.  Potential risk factors for the development of seroma following mastectomy with axillary dissection.

Authors:  Xiao-Feng Pan; Jin-Liang Huan; Xian-Ju Qin
Journal:  Mol Clin Oncol       Date:  2014-09-25

Review 6.  Whether drainage should be used after surgery for breast cancer? A systematic review of randomized controlled trials.

Authors:  Xiao-Dong He; Zhi-Hui Guo; Jin-Hui Tian; Ke-Hu Yang; Xiao-Dong Xie
Journal:  Med Oncol       Date:  2010-09-09       Impact factor: 3.064

7.  Post-operative seroma causing spontaneous nipple discharge: diagnosis by galactography.

Authors:  Ivan E Ramirez-Hernandez; Rulon L Hardman; Aaron D Kirkpatrick; Joseph Sutcliffe
Journal:  J Radiol Case Rep       Date:  2013-05-01

8.  Microporous polysaccharide hemospheres and seroma formation after mastectomy and axillary dissection in rats.

Authors:  Tufan Egeli; Ali İbrahim Sevinç; Seymen Bora; Mehmet Can Yakut; Tansu Cevizci; Tülay Canda; Ali Rıza Sişman
Journal:  Balkan Med J       Date:  2012-06-01       Impact factor: 2.021

Review 9.  Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and axillary surgery.

Authors:  Muhammad S Sajid; Kristian H Hutson; Ignazio F Rapisarda; Riccardo Bonomi
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

10.  The Use of TissuGlu® Surgical Adhesive for Mastectomy With or Without Lymphonodectomy.

Authors:  Ralf Ohlinger; Leonie Gieron; Rico Rutkowski; Thomas Kohlmann; Marek Zygmunt; Julia Unger
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.